Survivor Journeys
Read inspiring stories from survivors benefiting from research-driven advances against cancer, like head and neck cancer survivor Bill McCone of Pennsylvania.
Read Bill's Story
Read inspiring stories from survivors benefiting from research-driven advances against cancer, like head and neck cancer survivor Bill McCone of Pennsylvania.
Read Bill's Story
Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.
Learn More
Cancer Treatment During a Pandemic: People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.
Read More
The FDA has approved a new combination of immunotherapy and chemotherapy as an initial treatment for extensive-stage small cell lung cancer.
Learn More
A roundup of significant cancer research news from the past week, selected by the staff of Cancer Today magazine.
Learn More
Learn about cancer researchers and physician-scientists like former AACR President and Fellow of the AACR Academy Elizabeth M. Jaffee, MD, who are leading progress against cancer.
Learn More
Join the AACR Runners for Research for virtual runs this spring and summer to stay active and help raise critically needed funds for lifesaving cancer research.
Learn More
Notice of Termination and Rescheduling
The AACR Board of Directors has made the difficult decision, after careful consideration of currently available information related to the novel coronavirus outbreak, to terminate the AACR Annual Meeting 2020, originally scheduled for April 24-29 in San Diego, California. A rescheduled meeting is being planned for later this year.
The American Association for Cancer Research (AACR) and our more than 44,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.
Learn MoreEva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.
Learn MoreA physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn Morenew therapeutics against cancer were approved by the FDA from August 1, 2018, to July 31, 2019
Learn MoreYour donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Today